Andreas Barner" /> Andreas Barner" />

Please login to the form below

Not currently logged in

Boehringer appoints new chairman of the board

Hubertus vonBaumbach will succeed Andreas Barner
Hubert von Baumbach

Boehringer Ingelheim has appointed Hubertus von Baumbach as chairman of the board of managing directors with effect from June 2016.

Baumbach has been a member of the board of managing directors since 2009 and is head of the corporate board division of finance. He has also worked at Roche in the US and at Boehringer Ingelheim in Canada.

His appointment follows the move of the current chair, Andreas Barner, to the shareholders' committee.

Christian Boehringer, chair of the shareholders' committee, said: “This decision provided a successor who would ensure continuity whilst also looking to the future. Hubertus von Baumbach knows the corporation and its various divisions and his time on the board of managing directors has prepared him well for the company's future challenges.   

"Along with colleagues on the board of managing directors, he will continue the drive for change at Boehringer Ingelheim in order to secure the company's independence in the long term.”  

Also joining the board is Michel Pairet who will be responsible for the corporate business division of research and nonclinical development from January 1 2016. He formerly led the pharmacology unit at the research facility in Biberach

Article by
Nikhil Patel

9th November 2015

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...